Literature DB >> 25159134

Repeat CT-scan assessment of lymph node motion in locally advanced cervical cancer patients.

Luiza Bondar1, Laura Velema, Jan Willem Mens, Ellen Zwijnenburg, Ben Heijmen, Mischa Hoogeman.   

Abstract

PURPOSE: In cervical cancer patients the nodal clinical target volume (CTV, defined using the major pelvic blood vessels and enlarged lymph nodes) is assumed to move synchronously with the bony anatomy. The aim of this study was to verify this assumption by investigating the motion of the major pelvic blood vessels and enlarged lymph nodes visible in CT scans. METHODS AND MATERIALS: For 13 patients treated in prone position, four variable bladder-filling CT scans per patient, acquired at planning and after 40 Gy, were selected from an available dataset of 9-10 CT scans. The bladder, rectum, and the nodal-vessels structure containing the iliac vessels and all visible enlarged nodes were delineated in each selected CT scan. Two online patient setup correction protocols were simulated. The first corrected bony anatomy translations and the second corrected translations and rotations. The efficacy of each correction was calculated as the overlap between the nodal-vessels structure in the reference and repeat CT scans. The motion magnitude between delineated structures was quantified using nonrigid registration.
RESULTS: Translational corrections resulted in an average overlap of 58 ± 13% and in a range of motion between 9.9 and 27.3 mm. Translational and rotational corrections significantly improved the overlap (64 ± 13%, p value = 0.007) and moderately reduced the range of motion to 7.6-23.8 mm (p value = 0.03). Bladder filling changes significantly correlated with the nodal-vessels motion (p < 0.001).
CONCLUSION: The motion of the nodal-vessels was large, nonrigid, patient-specific, and only moderately synchronous with the bony anatomy. This study highlights the need for caution when reducing the CTV-to-PTV (PTV planning target volume) margin of the nodal CTV for highly conformal radiation techniques.

Entities:  

Mesh:

Year:  2014        PMID: 25159134     DOI: 10.1007/s00066-014-0720-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  18 in total

1.  Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.

Authors:  P J Eifel; J Moughan; J Owen; A Katz; I Mahon; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-15       Impact factor: 7.038

2.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer.

Authors:  Karen Lim; William Small; Lorraine Portelance; Carien Creutzberg; Ina M Jürgenliemk-Schulz; Arno Mundt; Loren K Mell; Nina Mayr; Akila Viswanathan; Anuja Jhingran; Beth Erickson; Jennifer De los Santos; David Gaffney; Catheryn Yashar; Sushil Beriwal; Aaron Wolfson; Alexandra Taylor; Walter Bosch; Issam El Naqa; Anthony Fyles
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-14       Impact factor: 7.038

3.  Residual rotational set-up errors after daily cone-beam CT image guided radiotherapy of locally advanced cervical cancer.

Authors:  Louise Vagner Laursen; Ulrik Vindelev Elstrøm; Anne Vestergaard; Ludvig P Muren; Jørgen Baltzer Petersen; Jacob Christian Lindegaard; Cai Grau; Kari Tanderup
Journal:  Radiother Oncol       Date:  2012-09-28       Impact factor: 6.280

4.  Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers.

Authors:  S Marnitz; C Köhler; A Rauer; A Schneider; V Budach; A Tsunoda; M Mangler
Journal:  Strahlenther Onkol       Date:  2013-07-27       Impact factor: 3.621

5.  Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies.

Authors:  A J Mundt; J C Roeske; A E Lujan; S D Yamada; S E Waggoner; G Fleming; J Rotmensch
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

6.  Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.

Authors:  Clark J Brixey; John C Roeske; Anthony E Lujan; S Diane Yamada; Jacob Rotmensch; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-12-01       Impact factor: 7.038

7.  Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.

Authors:  Robert Dinniwell; Philip Chan; Gregory Czarnota; Masoom A Haider; Kartik Jhaveri; Michael Jewett; Anthony Fyles; David Jaffray; Michael Milosevic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-25       Impact factor: 7.038

8.  Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.

Authors:  Arno J Mundt; Loren K Mell; John C Roeske
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-08-01       Impact factor: 7.038

9.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

10.  Treatment simulations with a statistical deformable motion model to evaluate margins for multiple targets in radiotherapy for high-risk prostate cancer.

Authors:  Sara Thörnqvist; Liv B Hysing; Andras G Zolnay; Matthias Söhn; Mischa S Hoogeman; Ludvig P Muren; Lise Bentzen; Ben J M Heijmen
Journal:  Radiother Oncol       Date:  2013-10-31       Impact factor: 6.280

View more
  1 in total

1.  Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.

Authors:  Peter de Boer; Agustinus J A J van de Schoot; Henrike Westerveld; Mark Smit; Marrije R Buist; Arjan Bel; Coen R N Rasch; Lukas J A Stalpers
Journal:  Strahlenther Onkol       Date:  2017-11-03       Impact factor: 3.621

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.